Second, studies have focused on AHDs, particularly calcium channel blockers, angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and β-blockers (BBs), for their role in mitigating AD-related pathology and their preventive effects. The gene discussed is ACE; the disease is Alzheimer disease.